DyNAbind is your preferred partner for fast, reliable DNA-Encoded Library drug discovery. Our novel technology platform offers our partners a better way to higher-quality, more relevant medicinal chemistry starting points for nearly any protein target, even traditionally difficult classes like protein-protein interactions. We're ready to work with you all the way through the discovery process, from de novo hit discovery to focused approaches for affinity and specificity maturation. Unlike traditional high-throughput screening methods that test chemicals one-by-one, our DNA-Encoded Library platform allows us to simultaneously select from hundreds of millions of molecules. Our proprietary innovations make this approach better than ever before, with dramatically improved signal-to-noise ratios, reduced false positive rates and rapid follow-up hit validation. In just a few weeks, DyNAbind can deliver results that would have taken over a year with older methodologies. As a dynamic start-up, we take pride in our customer focus. Whether you’re a big pharma, biotech or academic group working on innovative targets, we’re excited to sit together and create an ideal, customized workflow and financial framework to meet your discovery needs.